Observational studyBMC infectious diseases2026
Diagnostic utility of serum ferritin in culture proven bacterial infection: an observational study.
Observational study in BMC infectious diseases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionDiagnosing neonatal sepsis remains challenging due to the low yield of blood cultures. Most neonatal intensive care units (NICUs) rely on a sepsis screen for diagnosis. This study aimed to evaluate the diagnostic utility of serum ferritin as a standalone marker and in combination with the existing septic screen.
methodsThis prospective study was conducted between August 2023 and January 2024 in a level-III NICU and included 160 neonates with suspected sepsis who stayed in the NICU for more than 48 h. Sensitivity, specificity, and the area under the receiver operator curve (ROC) for serum ferritin were calculated in relation to culture-proven bacterial infection. The Youden Index was used to determine the optimal serum ferritin cut-off value.
resultsThe mean age of the neonates was 1.83 ± 2.26 days; 64% were boys, 69% were term, and 54% had low birth weight. Among the outcomes, 28% had positive blood cultures, 45% were septic screen positive, and 27% had clinical sepsis. The mean serum ferritin level was significantly higher in septic screen-positive neonates (426.9 ng/mL) than in culture-positive cases (326.61 ng/mL; p < 0.001). In neonates with blood culture-positive sepsis, a serum ferritin cut-off value of > 295.5 ng/mL yielded an Area Under Curve (AUC) of 0.70, sensitivity of 54%, and specificity of 86% (Youden Index: 0.403). The sepsis screen alone had an AUC of 0.58, sensitivity of 57%, and specificity of 60%. When serum ferritin was added to the septic screen, the AUC remained similar (0.59), sensitivity increased to 72%, but specificity decreased to 46%.
conclusionSerum ferritin levels were higher in septic screen-positive sepsis than in culture-positive sepsis. Adding serum ferritin (cut-off: >295 ng/mL) to the septic screen improved its sensitivity, albeit with reduced specificity. Serum ferritin has limited role adjunctive value, can have a role as a “rule - out” marker in diagnosing culture positive bacterial infection.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.